These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 12091215)

  • 21. Effects of topiramate on smoking in patients with schizoaffective disorder, bipolar type.
    Weinberger AH; George TP; Perkins KA; Chengappa KN
    J Clin Psychopharmacol; 2008 Apr; 28(2):247-8. PubMed ID: 18344743
    [No Abstract]   [Full Text] [Related]  

  • 22. Adjunctive topiramate for juvenile chronic organic mania.
    Basu S; Jagadheesan K; Gupta SC; Sinha VK
    Aust N Z J Psychiatry; 2004 Jun; 38(6):477. PubMed ID: 15209843
    [No Abstract]   [Full Text] [Related]  

  • 23. Cognitive changes during topiramate therapy.
    Davanzo P; Cantwell E; Kleiner J; Baltaxe C; Najera B; Crecelius G; McCracken J
    J Am Acad Child Adolesc Psychiatry; 2001 Mar; 40(3):262-3. PubMed ID: 11288765
    [No Abstract]   [Full Text] [Related]  

  • 24. Topiramate-induced depression.
    Klufas A; Thompson D
    Am J Psychiatry; 2001 Oct; 158(10):1736. PubMed ID: 11579016
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical outcome of adjunctive topiramate treatment in a sample of refractory bipolar patients with comorbid conditions.
    Guille C; Sachs G
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Oct; 26(6):1035-9. PubMed ID: 12452523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of acute mania with topiramate.
    Normann C; Langosch J; Schaerer LO; Grunze H; Walden J
    Am J Psychiatry; 1999 Dec; 156(12):2014. PubMed ID: 10588422
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of topiramate.
    Kruszewski SP; Klotz SG
    Am J Psychiatry; 2007 Mar; 164(3):526-7; author reply 527-8. PubMed ID: 17329483
    [No Abstract]   [Full Text] [Related]  

  • 28. Academy for Eating Disorders International Conference on Eating Disorders. Denver, CO, USA, May 29-31, 2003.
    Kaplan AS
    Expert Opin Investig Drugs; 2003 Aug; 12(8):1441-3. PubMed ID: 12882630
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Open-label adjunctive topiramate in the treatment of bipolar disorders.
    McElroy SL; Suppes T; Keck PE; Frye MA; Denicoff KD; Altshuler LL; Brown ES; Nolen WA; Kupka RW; Rochussen J; Leverich GS; Post RM
    Biol Psychiatry; 2000 Jun; 47(12):1025-33. PubMed ID: 10862801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Topiramate abuse in a bipolar patient with an eating disorder.
    Colom F; Vieta E; Benabarre A; Martínez-Arán A; Reinares M; Corbella B; Gastó C
    J Clin Psychiatry; 2001 Jun; 62(6):475-6. PubMed ID: 11465528
    [No Abstract]   [Full Text] [Related]  

  • 31. Third generation anticonvulsants in bipolar disorder: a review of efficacy and summary of clinical recommendations.
    Yatham LN; Kusumakar V; Calabrese JR; Rao R; Scarrow G; Kroeker G
    J Clin Psychiatry; 2002 Apr; 63(4):275-83. PubMed ID: 12000201
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adjunctive topiramate in the maintenance treatment of bipolar disorders: an open-label study.
    Lykouras L; Hatzimanolis J
    Curr Med Res Opin; 2004 Jun; 20(6):843-7. PubMed ID: 15200741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bipolar disorders and the effectiveness of novel anticonvulsants.
    Calabrese JR; Shelton MD; Rapport DJ; Kimmel SE
    J Clin Psychiatry; 2002; 63 Suppl 3():5-9. PubMed ID: 11908919
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lithium augmentation of topiramate for bipolar disorder with comorbid binge eating disorder and obesity.
    Kotwal R; Guerdjikova A; McElroy SL; Keck PE
    Hum Psychopharmacol; 2006 Oct; 21(7):425-31. PubMed ID: 16941522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Topiramate in treatment-resistant depression and binge-eating disorder.
    Schmidt do Prado-Lima PA; Bacaltchuck J
    Bipolar Disord; 2002 Aug; 4(4):271-3. PubMed ID: 12190717
    [No Abstract]   [Full Text] [Related]  

  • 36. First break of mania associated with topiramate treatment.
    Schlatter FJ; Soutullo CA; Cervera-Enguix S
    J Clin Psychopharmacol; 2001 Aug; 21(4):464-6. PubMed ID: 11476138
    [No Abstract]   [Full Text] [Related]  

  • 37. Topiramate for abnormal eating behaviour in frontotemporal dementia.
    Singam C; Walterfang M; Mocellin R; Evans A; Velakoulis D
    Behav Neurol; 2013 Jan; 27(3):285-6. PubMed ID: 23548883
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential effects of topiramate in patients with traumatic brain injury and obesity--a case series.
    Dolberg OT; Barkai G; Gross Y; Schreiber S
    Psychopharmacology (Berl); 2005 Jun; 179(4):838-45. PubMed ID: 15619108
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of topiramate in bulimia nervosa and binge-eating disorder: a systematic review.
    Arbaizar B; Gómez-Acebo I; Llorca J
    Gen Hosp Psychiatry; 2008; 30(5):471-5. PubMed ID: 18774432
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Topiramate induced manic episode.
    Jochum T; Bär KJ; Sauer H
    J Neurol Neurosurg Psychiatry; 2002 Aug; 73(2):208-9. PubMed ID: 12122191
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.